Jim Robinson
InvestorSenior Advisor at Adjuvant Capital
About
Jim Robinson is a biologics manufacturing expert who served as Vice President, Global Technical Operations, Vaccines, Biological and Sterile Products at Merck & Co. from 2010 to 2015, and earlier as Vice President, Technical and Quality Operations at Novavax from 2007 to 2010. He previously spent about 20 years at Sanofi Pasteur, including as Vice President, Industrial Operations from 1998 to 2006. He holds Master's and Bachelor's degrees in Chemical Engineering from Lehigh University and serves on several scientific advisory boards, including as Vice Chair of CEPI's Scientific Advisory Committee.
Invests in
Biotech
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
David Washer
Investor at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital